Case Reports
[Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy]
[Article in
Spanish]
- PMID: 7538188
Item in Clipboard
Case Reports
[Paradoxical myelosuppression with granulocyte-stimulating factor (G-CSF) and simultaneous administration chemotherapy]
[Article in
Spanish]
Med Clin (Barc).
.
No abstract available
Comment in
-
[The paradox of G-CSF].Med Clin (Barc). 1994 May 14;102(18):718-9. Med Clin (Barc). 1994. PMID: 7518024 Spanish. No abstract available.
Similar articles
-
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.Clin Cancer Res. 1997 Sep;3(9):1519-26. Clin Cancer Res. 1997. PMID: 9815838 Clinical Trial.
-
[Prophylactic use of hematopoietic growth factors (G-CSF, GM-CSF) in prevention of chemotherapy-induced myelosuppression in children].Wiad Lek. 2003;56(3-4):152-6. Wiad Lek. 2003. PMID: 12923962 Polish.
-
Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).Eur Cytokine Netw. 2001 Apr-Jun;12(2):231-8. Eur Cytokine Netw. 2001. PMID: 11399510
-
[Granulocyte colony-stimulating factors as a support therapy in malignant diseases].Duodecim. 2002;118(21):2249-54. Duodecim. 2002. PMID: 12486962 Review. Finnish. No abstract available.
-
Granulocyte colony-stimulating factor administration: adverse events.Transfus Med Rev. 2008 Oct;22(4):280-90. doi: 10.1016/j.tmrv.2008.05.005. Transfus Med Rev. 2008. PMID: 18848155 Review.